It Has Also Entered Into An Agreement With Enzychem Lifesciences Of The Republic Of Korea For The Manufacturing License And Technology Transfer For The Plasmid Dna Vaccine, Zydus Cadila Noted. Zydus Cadila On Wednesday Said It Has Commenced Supplies Of Its Covid-19 Vaccine Zycov-D To The Central Government. The Company Has Initiated The Supply As Per The Order Placed By The Government, The Drug Firm Said In A Statement. The Group Is Also Planning To Make The Vaccine Available In The Private Market, It Added. Zycov-D Is A Three-Dose Vaccine Administered Intradermally. "The Vaccine Will Be Priced At Rs 265 Per Dose And The Applicator Being Offered At Rs 93 Per Dose, Excluding Gst," Zydus Cadila Said. The Ahmedabad-Based Drugmaker Has Also Entered Into A Definitive Agreement With Shilpa Medicare Ltd, A Contract Manufacturing Organisation, To Produce Mutually Agreeable Doses Of Zycov-D. It Has Also Entered Into An Agreement With Enzychem Lifesciences Of The Republic Of Korea For The Manufacturing License And Technology Transfer For The Plasmid Dna Vaccine, Zydus Cadila Noted. Zycov-D Is A Plasmid Dna Vaccine That Produces The Spike Protein Of The Sarscov-2 Virus And Elicits An Immune Response Mediated By The Cellular And Humoral Arms Of The Human Immune System, Which Play A Vital Role In Protection From Disease As Well As Viral Clearance.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!